Shanghai Pharmaceuticals Holding Co., Ltd
601607
Peringkat dalam Saham
#2387
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Harga Saham
$2.43
Kapitalisasi Pasar
$8.09B
Perubahan (1 hari)
-1.16%
Perubahan (1 tahun)
-5.94%
Negara
CN
Perdagangan Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Kategori
Healthcare
Laba untuk Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Shanghai Pharmaceuticals Holding Co., Ltd, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Shanghai Pharmaceuticals Holding Co., Ltd dari 2001 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2025 | $1.40B | 27.74% |
| 2024 | $1.10B | 10.26% |
| 2023 | $996.57M | -21.96% |
| 2022 | $1.28B | -0.34% |
| 2021 | $1.28B | 16.65% |
| 2020 | $1.10B | 22.13% |
| 2019 | $899.35M | 15.77% |
| 2018 | $776.81M | -2.90% |
| 2017 | $799.98M | 19.73% |
| 2016 | $668.16M | 4.00% |
| 2015 | $642.44M | 4.72% |
| 2014 | $613.46M | 15.36% |
| 2013 | $531.78M | 7.40% |
| 2012 | $495.16M | 2.85% |
| 2011 | $481.45M | 46.27% |
| 2010 | $329.15M | 533.08% |
| 2009 | $51.99M | 90.01% |
| 2008 | $27.36M | 36.33% |
| 2007 | $20.07M | 54.40% |
| 2006 | $13.00M | 6.28% |
| 2005 | $12.23M | -46.95% |
| 2004 | $23.06M | -26.01% |
| 2003 | $31.16M | 20.81% |
| 2002 | $25.79M | 5.48% |
| 2001 | $24.45M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $6.46B | - |
US
|
|
| - | - |
US
|
|
| $2.17B | - |
US
|
|
| - | - |
US
|
|
| $708.86M | - |
AU
|
